http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006028194-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999fee6428152a996011d506925c2d7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2005-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_192ac00178ebd8e74f9f22f0ebabc5a1 |
| publicationDate | 2006-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006028194-A |
| titleOfInvention | Pharmaceutical composition for abnormal glucose tolerance and food and drink |
| abstract | Disclosed is a drug (pharmaceutical composition and food / drink product) that effectively acts on impaired glucose tolerance and is excellent in safety, which is difficult to treat with conventional pharmaceuticals. Disclosed is a drug for abnormal glucose tolerance, which contains at least one branched chain amino acid of leucine, isoleucine and valine as an active ingredient. Glucose tolerance abnormalities such as diabetes can be treated and prevented. In particular, it is suitable for patients with liver disorders, and can be used in the form of pharmaceuticals such as drugs for liver diseases, or in the form of foods and beverages such as health foods or in the form used therefor. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113797188-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009179633-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962678-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008004340-A1 |
| priorityDate | 2001-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.